JAPM in collaboration with JFDA announces the opening of registration in a Workshop titled:

ICH M13 New Guideline on Bioequivalence For Immediate Release Solid Oral Dosage Forms Workshop

“Highlights on the new requirements”

 Which will be effective in Jordan as of April 1, 2025

The workshop will also address the current JFDA Guideline and requirements for Bio-waiver Studies

Who Should Attend:

RA and R&D people at pharmaceutical companies

Speakers: JFDA/ Drug Directorate

Venue: Signia by Hilton Amman (Ex. Kempisnki Hotel- Amman) 

https://maps.app.goo.gl/hxXEFe1hQt2X8ADZ8?g_st=im

Registration Form:

https://docs.google.com/forms/d/e/1FAIpQLSfNBQ_HD_6pZMbQQdFD-xCfBIFiNue5ioKHBwEy1uM4m4S2gA/viewform?usp=dialog

For more information email: dana@japm.com or call JAPM offices on +962 6 5413114